Sana Biotechnology, Inc. Common Stock (SANA) is a publicly traded Healthcare sector company. As of November 5, 2026, SANA trades at $2.43 with a market cap of $766.36M and a P/E ratio of -3.00. SANA moved -9.38% today. Year to date, SANA is -42.73%; over the trailing twelve months it is -43.01%. Its 52-week range spans $1.26 to $6.55. Analyst consensus is strong buy with an average price target of $8.00. Rallies surfaces SANA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for SANA, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $2.43 |
| Market Cap | $766.36M |
| P/E Ratio | -3.00 |
| EPS | $-0.96 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.55 |
| 52-Week Low | $1.26 |
| Volume | 2.59M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-244.17M |
| Gross Margin | 0.00% |
5 analysts cover SANA: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $8.00.